Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction
- PMID: 3079764
Human liver microsomal cytochrome P-450 mephenytoin 4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism. Purification and characterization of two similar forms involved in the reaction
Abstract
Two forms of cytochrome P-450 (P-450), designated P-450MP-1 and P-450MP-2, were purified to electrophoretic homogeneity from human liver microsomes on the basis of mephenytoin 4-hydroxylase activity. Purified P-450MP-1 and P-450MP-2 contained 12-17 nmol of P-450/mg of protein and had apparent monomeric molecular weights of 48,000 and 50,000, respectively. P-450MP-1 and P-450MP-2 were found to be very similar proteins as judged by chromatographic behavior on n-octylamino-Sepharose 4B, hydroxylapatite, and DEAE- and CM-cellulose columns, spectral properties, amino acid composition, peptide mapping, double immunodiffusion analysis, immunoinhibition, and N-terminal amino acid sequences. In vitro translation of liver RNA yielded polypeptides migrating with P-450MP-1 or P-450MP-2, depending upon which form was in each sample, indicating that the two P-450s are translated from different mRNAs. When reconsituted with NADPH-cytochrome-P-450 reductase and L-alpha-dilauroyl-sn-glyceryo-3-phosphocholine, P-450MP-1 and P-450MP-2 gave apparently higher turnover numbers for mephenytoin 4-hydroxylation than did the P-450 in the microsomes. The addition of purified rat or human cytochrome b5 to the reconstituted system caused a significant increase in the hydroxylation activity; the maximum stimulation was obtained when the molar ratio of cytochrome b5 to P-450 was 3-fold. Rabbit anti-human cytochrome b5 inhibited NADH-cytochrome-c reductase and S-mephenytoin 4-hydroxylase activities in human liver microsomes. In the presence of cytochrome b5, the Km value for S-mephenytoin was 1.25 mM with all five purified cytochrome P-450s preparations, and Vmax values were 0.8-1.25 nmol of 4-hydroxy product formed per min/nmol of P-450. P-450MP is a relatively selective P-450 form that metabolizes substituted hydantoins well. Reactions catalyzed by purified P-450MP-1 and P-450MP-2 preparations and inhibited by anti-P-450MP in human liver microsomes include S-mephenytoin 4-hydroxylation, S-nirvanol 4-hydroxylation, S-mephenytoin N-demethylation, and diphenylhydantoin 4-hydroxylation. Thus, at least two very similar forms of human P-450 are involved in S-mephenytoin 4-hydroxylation, an activity which shows genetic polymorphism.
Similar articles
-
Characterization of CYP2C19 and CYP2C9 from human liver: respective roles in microsomal tolbutamide, S-mephenytoin, and omeprazole hydroxylations.Arch Biochem Biophys. 1998 May 1;353(1):16-28. doi: 10.1006/abbi.1998.0615. Arch Biochem Biophys. 1998. PMID: 9578596
-
Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase.Biochemistry. 1988 Sep 6;27(18):6929-40. doi: 10.1021/bi00418a039. Biochemistry. 1988. PMID: 3196692
-
Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes.Mol Pharmacol. 1991 Jul;40(1):69-79. Mol Pharmacol. 1991. PMID: 1857342
-
Polymorphism in stereoselective hydroxylations of mephenytoin and hexobarbital by Japanese liver samples in relation to cytochrome P-450 human-2 (IIC9).Xenobiotica. 1992 Sep-Oct;22(9-10):1083-92. doi: 10.3109/00498259209051862. Xenobiotica. 1992. PMID: 1441599 Review.
-
Genetic polymorphism of mephenytoin metabolism.Prog Clin Biol Res. 1986;214:139-56. Prog Clin Biol Res. 1986. PMID: 3523505 Review. No abstract available.
Cited by
-
Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.Biochem J. 1992 Jan 15;281 ( Pt 2)(Pt 2):359-68. doi: 10.1042/bj2810359. Biochem J. 1992. PMID: 1736885 Free PMC article.
-
Evidence for cytochrome P-450NF, the nifedipine oxidase, being the principal enzyme involved in the bioactivation of aflatoxins in human liver.Proc Natl Acad Sci U S A. 1989 Jan;86(2):462-5. doi: 10.1073/pnas.86.2.462. Proc Natl Acad Sci U S A. 1989. PMID: 2492107 Free PMC article.
-
An NH2-terminal truncated cytochrome P450 CYP3A4 showing catalytic activity is present in the cytoplasm of human liver cells.Exp Mol Med. 2008 Apr 30;40(2):254-60. doi: 10.3858/emm.2008.40.2.254. Exp Mol Med. 2008. PMID: 18446064 Free PMC article.
-
Influence of tumor size on the main drug-metabolizing enzyme systems in mouse colon adenocarcinoma Co38.Cancer Chemother Pharmacol. 1994;34(6):497-502. doi: 10.1007/BF00685661. Cancer Chemother Pharmacol. 1994. PMID: 7923560
-
Relationship between phenytoin and tolbutamide hydroxylations in human liver microsomes.Br J Clin Pharmacol. 1991 Feb;31(2):125-30. doi: 10.1111/j.1365-2125.1991.tb05499.x. Br J Clin Pharmacol. 1991. PMID: 2049228 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases